Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Current Opinion in Pharmacology|January 3, 2024
Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunctionKeith W WardExpert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Recent advances in pharmacokinetic extrapolation from preclinical data to humansKeith W WardOptometry and Vision Science : Official Publication of the American Academy of Optometry|January 5, 2008
Superficial punctate fluorescein staining of the ocular surfaceKeith W WardJournal of Pharmaceutical Sciences|September 7, 2004
A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humansRakesh Nagilla, Keith W WardDrug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence timeKeith W Ward, Brian R SmithThe Journal of Pharmacology and Experimental Therapeutics|April 2, 2004
Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCl salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, dog, and monkeyKeith W Ward, Leonard M AzzaranoInternational Journal of Toxicology|October 2, 2010
WY-14 643, a selective PPAR{alpha} agonist, induces proinflammatory and proangiogenic responses in human ocular cellsJin-Zhong Zhang, Keith W WardDrug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. ClearanceKeith W Ward, Brian R SmithJournal of Pharmaceutical Sciences|October 24, 2007
Cassette dosing pharmacokinetic studies for evaluation of ophthalmic drugs for posterior ocular diseasesJoel W Proksch, Keith W WardThe Journal of Antimicrobial Chemotherapy|October 30, 2007
Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytesJin-Zhong Zhang, Keith W WardPageof 7